Figure 4From: Proteins of the VEGFR and EGFR pathway as predictive markers for adjuvant treatment in patients with stage II/III colorectal cancer: results of the FOGT-4 trialOverall survival analysis for patients according to tumor PTEN-status. A. in the whole population B. in the subgroup treated with adjuvant 5-FU/FA/irinotecan.Back to article page